Related Experiment Video
Updated: Oct 14, 2025

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study
Alvaro Sanchez-Larsen1, Estefanía Conde-Blanco2, Alejandro Viloria-Alebesque3
1Department of Neurology, Albacete University Hospital Complex, Albacete, Spain.
Insights
COVID-19 was moderately prevalent in people with epilepsy (PWE), with higher hospitalization and mortality rates compared to the general population. However, seizure control remained stable for most PWE during and after infection.
Area of Science:
- Neurology
- Infectious Diseases
- Epidemiology
Background:
- Assessing the impact of COVID-19 on people with epilepsy (PWE) is crucial.
- Understanding COVID-19 prevalence, severity, and mortality in PWE is essential.
- Evaluating seizure control in PWE during and after COVID-19 infection is a key concern.
Purpose of the Study:
- To determine the prevalence, severity, and mortality of COVID-19 in people with epilepsy (PWE).
- To evaluate seizure control in PWE during and after COVID-19 infection.
Main Methods:
- A retrospective, observational, multicenter study was conducted across 14 hospitals.
- Medical records of randomly selected PWE from neurology outpatient clinics were reviewed.
- COVID-19 prevalence, risk factors, and morbimortality in PWE were analyzed.
Main Results:
- COVID-19 prevalence in PWE was 5.53%, higher than the Spanish population (4.26%).
- PWE experienced higher rates of hospitalization (17.1% vs 10.81%), ICU admission (2% vs 0.95%), and death (4.61% vs 2.57%) from COVID-19.
- Older age, dyslipidemia, institutionalization, and intellectual disability were risk factors for severe COVID-19 and mortality. Seizure control remained stable in 90.1% during acute infection, with 8.6% reporting increased seizures.
Conclusions:
- COVID-19 is moderately prevalent in PWE, with increased risks of severe disease and death.
- Risk factors for severe COVID-19 and mortality in PWE include older age, dyslipidemia, institutionalization, and intellectual disability.
- Seizure control generally remained stable in PWE during and after COVID-19 infection, despite increased risks.
Background:
To assess the prevalence, severity, and mortality of COVID-19 in people with epilepsy (PWE) and evaluate seizure control in PWE during and after COVID-19.
Methods:
Retrospective, observational, multicenter study conducted in 14 hospitals. Medical records of randomly selected PWE followed at neurology outpatient clinics were reviewed. Proportion of PWE with a positive test for SARS-CoV-2 during 2020 was calculated. Risk factors associated with COVID-19 and its morbimortality were evaluated.
Results:
2751 PWE were included, mean age 48.8 years (18-99), 72.4% had focal epilepsy, and 35% were drug-refractory. COVID-19 prevalence in PWE was 5.53%, while in the Spanish population was 4.26%. Proportion of admissions to hospital, ICU, and deaths in PWE were 17.1%, 2%, and 4.61% of COVID-19 cases, while in Spanish population were 10.81%, 0.95%, and 2.57%, respectively. A severe form of COVID-19 occurred in 11.8%; dyslipidemia, institutionalization at long-term care facilities, intellectual disability, and older age were associated risk factors. Older age, hypertension, dyslipidemia, cardiac disease, and institutionalization were associated with mortality from COVID-19. Seizure control was stable in 90.1% of PWE during acute COVID-19, while 8.6% reported an increase in seizure frequency. During post-COVID-19 follow-up, 4.6% reported seizure control worsening.
Conclusions:
COVID-19 was moderately prevalent in PWE. One out of 5 patients required medical attention and 4.6% died due to COVID-19. Older age, dyslipidemia, institutionalization, and intellectual disability were significant risk factors associated with severe COVID-19. Seizure control remained stable during COVID-19 and throughout long-term follow-up in most PWE who contracted the infection.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
05:33A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Bias in Epidemiological Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies